NDRAENDRA Life Sciences Inc.

NAS · US · Healthcare · Diagnostics & Research · endrainc.com

4.490USD-0.66%Mkt Cap: 6.73M $P/E: —3d ago

ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc.

Agilent Technologies, Inc.

$44.91BUSDP/E 31.9

IDXX

IDEXX Laboratories, Inc.

Mettler-Toledo International, Inc.

$27.96BUSDP/E 31.5

Labcorp Holdings Inc.

$27.28BUSDP/E 27.8

DGX

Quest Diagnostics Incorporated

$26.97BUSDP/E 26.0

Guardant Health, Inc.

$22.91BUSD

MEDP

Medpace Holdings, Inc.

$17.33BUSDP/E 36.4

ERF

Eurofins Scientific SE

$13.65BUSDP/E 25.3

CRL

Charles River Laboratories International, Inc.

$14.09BUSD

RVTY

Revvity Inc. Common Stock

$13.92BUSDP/E 59.7

ICLR

ICON Public Limited Company

Twist Bioscience Corp.

$9.13BUSD

Key Statistics

Company

Market Cap6.73M $

Enterprise Value5.78M $

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-7.03M $

Revenue/Share—

Last Price4.490 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees9

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.51

PEG—

EV/EBITDA-0.90

EV/Revenue—

P/S—

P/B3.18

EPS (TTM)-6.26

EPS (Forward)-3.04

52W Range

2.96022% of range9.850

52W High9.850 USD

52W Low2.960 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-310.93%

ROA-182.35%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.18M $

CapEx (TTM)3.02M $

FCF Margin—

FCF Yield-80.53%

Net Debt104.74K $

Net Debt/EBITDA-0.02

Balance Sheet

Debt/Equity0.22

Current Ratio0.64

Quick Ratio0.43

Book Value/Sh1.440 USD

Cash/Share0.2810 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:35

Split DateNov 7, 2024

Analyst Consensus

Rating—

Target (Mean)25.00 USD

Upside (mean)+456.8%

Target Range25.00 USD – 25.00 USD

# Analysts1

Ownership

Shares Out.1.50M

Float1.20M

Insiders8.73%

Institutions12.67%

Short Interest

Short Ratio1.2d

Short % Float2.75%

Short % Out.2.59%

Shares Short32.95K

Short (prev mo.)42.12K

Technical

SMA 504.847 (-7.4%)

SMA 2004.784 (-6.1%)

Beta-0.07

S&P 52W Chg18.16%

Avg Vol (30d)25.78K

Avg Vol (10d)16.70K

Technical Indicators

RSI (14)45.6

MACD-0.1325

MACD Signal-0.1500

MACD Hist.+0.0175

BB Upper4.994 USD

BB Middle4.534 USD

BB Lower4.075 USD

BB Width20.27%

ATR (14)0.3367 USD

Vol Ratio (20d)1.61x